Dylan L. Steen

发表

American College of Cardiology, 64th Annual Scientific Session & Expo: Advisors' Introduction

Robert P. Giugliano, Nihar R. Desai, Dylan L. Steen, 2015 .

Shared decision‐making tool for thromboprophylaxis in atrial fibrillation – A feasibility study

Dylan L. Steen, Brett M. Harnett, A. Leonard, 2018, American heart journal.

A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality.

Dylan L. Steen, R. Giugliano, R. Wadhera, 2016, Journal of clinical lipidology.

Widening the path and window of opportunity for FDA approval of non-vitamin K oral anticoagulant specific antidotes and reversal agents

Dylan L. Steen, Sunny Patel, 2016, Journal of Thrombosis and Thrombolysis.

Predictors of Nonuse of a High‐Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib‐Thrombolysis in Myocardial Infarction 52 (SOLID‐TIMI 52) Trial

Dylan L. Steen, E. Braunwald, C. Cannon, 2017, Journal of the American Heart Association.

Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial

Dylan L. Steen, M. Sabatine, E. Braunwald, 2018, JAMA cardiology.

Highlights from the 2017 American Heart Association Scientific Sessions in Anaheim, California

Dylan L. Steen, 2018, Journal of Thrombosis and Thrombolysis.

Event Rates and Risk Factors for Recurrent Cardiovascular Events and Mortality in a Contemporary Post Acute Coronary Syndrome Population Representing 239 234 Patients During 2005 to 2018 in the United States

Dylan L. Steen, R. Giugliano, I. Khan, 2022, Journal of the American Heart Association.

Open access to an outpatient intravenous diuresis program in a systolic heart failure disease management program.

Dylan L. Steen, L. Tamariz, K. Hebert, 2011, Congestive heart failure.

Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines

Dylan L. Steen, D. Ansell, K. Ray, 2017, BMJ Open.

Statin potency associated with incident diabetes in a real-world evaluation

Dylan L. Steen, Deepak L. Bhatt, 2013, Evidence-Based Medicine.

Effect of Darapladib onMajor Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial

Dylan L. Steen, Marc P. Bonaca, E. Braunwald, 2014 .

Lp-PLA2 Inhibitors for the Reduction of Cardiovascular Events

Dylan L. Steen, M. O’Donoghue, 2013, Cardiology and Therapy.

Highlights from the 2018 European Society of Cardiology Congress in Munich, Germany

Dylan L. Steen, 2019, Journal of Thrombosis and Thrombolysis.

Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research

Dylan L. Steen, M. Pencina, E. Peterson, 2019, JAMA cardiology.

RECURRENT CARDIOVASCULAR EVENT RATES IN A CONTEMPORARY COHORT OF 829,498 ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE

Dylan L. Steen, M. Pencina, E. Peterson, 2017 .

Prognostic Evaluation of Catalytic Iron in Patients With Acute Coronary Syndromes

Dylan L. Steen, C. Cannon, D. Morrow, 2013, Clinical cardiology.

Highlights from the European society of cardiology congress 2020

Dylan L. Steen, Pooneh Nabavizadeh, 2021, Journal of Thrombosis and Thrombolysis.

Highlights from the 2018 American Heart Association Scientific Sessions in Chicago, Illinois

Dylan L. Steen, 2019, Journal of Thrombosis and Thrombolysis.

Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General Practice.

Dylan L. Steen, J. Ferrières, D. Ansell, 2018, Clinical therapeutics.

Highlights from the 2019 American College of Cardiology Scientific Sessions in New Orleans, LA

Dylan L. Steen, 2019, Journal of Thrombosis and Thrombolysis.

Highlights from the 2018 American College of Cardiology scientific session in Orlando, Florida

Dylan L. Steen, 2018, Journal of Thrombosis and Thrombolysis.

The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT–TIMI 22

Dylan L. Steen, C. Cannon, N. Khan, 2018, Clinical cardiology.

Atrial fibrillation decision support tool: Population perspective

Dylan L. Steen, Brett M. Harnett, A. Leonard, 2017, American heart journal.

Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation.

Dylan L. Steen, Brett M. Harnett, G. Lip, 2016, American heart journal.

Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age

Dylan L. Steen, Brett M. Harnett, A. Leonard, 2016, Journal of the American Geriatrics Society.

Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population

Dylan L. Steen, L. Tamariz, K. Hebert, 2010, European journal of heart failure.

Anacetrapib: potential for the prevention and treatment of coronary heart disease

Dylan L. Steen, A. Khera, C. Cannon, 2013 .

Prevalence of electrocardiographic abnormalities in a systolic heart failure disease management population by race, ethnicity, and sex.

Dylan L. Steen, K. Hebert, R. Colombo, 2010, Congestive heart failure.

Efficacy of supermarket and web-based interventions for improving dietary quality: a randomized, controlled trial

Dylan L. Steen, B. Saelens, M. Eckman, 2022, Nature Medicine.

Patterns and predictors of lipid‐lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed‐care population

Dylan L. Steen, R. Giugliano, J. Foody, 2017, Clinical cardiology.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

Dylan L. Steen, Marc P. Bonaca, E. Braunwald, 2014, JAMA.

Design and Rationale for the Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction Trial.

Dylan L. Steen, Deepak L. Bhatt, B. Saelens, 2022, American heart journal.

Prevalence of Conduction Abnormalities in a Systolic Heart Failure Population by Race, Ethnicity, and Gender

Dylan L. Steen, L. Tamariz, K. Hebert, 2012, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Highlights from the 2017 American Heart Association Scientific Sessions in Anaheim, California

Dylan L. Steen, 2018, Journal of Thrombosis and Thrombolysis.

Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial

Dylan L. Steen, M. Sabatine, E. Braunwald, 2018, JAMA cardiology.

Highlights from the 2018 American College of Cardiology scientific session in Orlando, Florida

Dylan L. Steen, 2018, Journal of Thrombosis and Thrombolysis.